• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

FACEmemory,一种创新的自我管理在线记忆评估工具。

FACEmemory, an Innovative Self-Administered Online Memory Assessment Tool.

作者信息

Alegret Montserrat, Blazquez-Folch Josep, Pérez Alba, Ortega Gemma, Espinosa Ana, Muñoz Nathalia, Sanabria Angela, García-Gutiérrez Fernando, Alarcon-Martin Emilio, Rosende-Roca Maitee, Vargas Liliana, Tartari Juan Pablo, Rentz Dorene M, Valero Sergi, Ruiz Agustín, Boada Mercè, Marquié Marta

机构信息

Ace Alzheimer Center Barcelona, Universitat Internacional de Catalunya, 08028 Barcelona, Spain.

Networking Research Center on Neurodegenerative Diseases (CIBERNED), Instituto de Salud Carlos III, 28029 Madrid, Spain.

出版信息

J Clin Med. 2024 Nov 29;13(23):7274. doi: 10.3390/jcm13237274.

DOI:10.3390/jcm13237274
PMID:39685733
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11642491/
Abstract

: Alzheimer's disease (AD) dementia and mild cognitive impairment (MCI) are currently underdiagnosed in the community, and early detection of cognitive deficits is crucial for timely intervention. FACEmemory, the first completely self-administered online memory test with voice recognition, has been launched as an accessible tool to detect such deficits. This study aims to investigate the neuropsychological associations between FACEmemory subscores and cognitive composites derived from traditional paper-and-pencil neuropsychological tests and to develop an optimal algorithm using FACEmemory data and demographics to discriminate cognitively healthy (CH) individuals from those with MCI. : A total of 669 participants (266 CH, 206 non-amnestic MCI [naMCI], and 197 amnestic MCI [aMCI]) were included. Multiple linear regression analyses were conducted using a cognitive composite as the dependent variable and FACEmemory subscores and demographic data (age, sex, and schooling) as independent variables. Machine learning models were compared to identify an optimal algorithm for distinguishing between CH and MCI (whole MCI, aMCI, and naMCI). : Multiple regression analyses showed associations between FACEmemory scores and the domains of memory (ρ = 0.67), executive functions (ρ = 0.63), visuospatial/visuoperceptual abilities (ρ = 0.55), language (ρ = 0.43), praxis (ρ = 0.52), and attention (ρ = 0.31). An optimal algorithm distinguished between CH and aMCI, achieving a FACEmemory cutoff score of 44.5, with sensitivity and specificity values of 0.81 and 0.72, respectively. : FACEmemory is a promising online tool for identifying early cognitive impairment, particularly aMCI. It may contribute to addressing the underdiagnosis of MCI and dementia in the community and in promoting preventive strategies.

摘要

阿尔茨海默病(AD)性痴呆和轻度认知障碍(MCI)目前在社区中未得到充分诊断,认知缺陷的早期检测对于及时干预至关重要。FACEmemory是首个完全自主进行的具有语音识别功能的在线记忆测试,已作为一种可获取的工具推出,用于检测此类缺陷。本研究旨在调查FACEmemory子分数与源自传统纸笔神经心理测试的认知综合指标之间的神经心理学关联,并使用FACEmemory数据和人口统计学信息开发一种最佳算法,以区分认知健康(CH)个体与MCI个体。:共纳入669名参与者(266名CH、206名非遗忘型MCI [naMCI]和197名遗忘型MCI [aMCI])。使用认知综合指标作为因变量,FACEmemory子分数和人口统计学数据(年龄、性别和受教育程度)作为自变量进行多元线性回归分析。比较机器学习模型以确定区分CH和MCI(整体MCI、aMCI和naMCI)的最佳算法。:多元回归分析显示FACEmemory分数与记忆领域(ρ = 0.67)、执行功能(ρ = 0.63)、视觉空间/视觉感知能力(ρ = 0.55)、语言(ρ = 0.43)、运用能力(ρ = 0.52)和注意力(ρ = 0.31)之间存在关联。一种最佳算法区分了CH和aMCI,FACEmemory截止分数为44.5,敏感性和特异性值分别为0.81和0.72。:FACEmemory是一种用于识别早期认知障碍,尤其是aMCI的有前景的在线工具。它可能有助于解决社区中MCI和痴呆的诊断不足问题,并促进预防策略的实施。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2fd7/11642491/c74671608946/jcm-13-07274-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2fd7/11642491/b41ca8b8cffb/jcm-13-07274-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2fd7/11642491/c74671608946/jcm-13-07274-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2fd7/11642491/b41ca8b8cffb/jcm-13-07274-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2fd7/11642491/c74671608946/jcm-13-07274-g002.jpg

相似文献

1
FACEmemory, an Innovative Self-Administered Online Memory Assessment Tool.FACEmemory,一种创新的自我管理在线记忆评估工具。
J Clin Med. 2024 Nov 29;13(23):7274. doi: 10.3390/jcm13237274.
2
A computerized version of the Short Form of the Face-Name Associative Memory Exam (FACEmemory®) for the early detection of Alzheimer's disease.一种用于早期检测阿尔茨海默病的人脸联想记忆测验(FACEmemory®)简体中文简化版的计算机版本。
Alzheimers Res Ther. 2020 Mar 16;12(1):25. doi: 10.1186/s13195-020-00594-6.
3
Automatized FACEmemory® scoring is related to Alzheimer's disease phenotype and biomarkers in early-onset mild cognitive impairment: the BIOFACE cohort.自动化FACEmemory®评分与早发性轻度认知障碍中的阿尔茨海默病表型和生物标志物相关:BIOFACE队列研究
Alzheimers Res Ther. 2022 Mar 18;14(1):43. doi: 10.1186/s13195-022-00988-8.
4
FACEmemory®, an Innovative Online Platform for Episodic Memory Pre-Screening: Findings from the First 3,000 Participants.FACEmemory®,一个用于情景记忆预筛查的创新型在线平台:来自前 3000 名参与者的发现。
J Alzheimers Dis. 2024;97(3):1173-1187. doi: 10.3233/JAD-230983.
5
Differential diagnosis of mild cognitive impairment of Alzheimer's disease by Simoa p-tau181 measurements with matching plasma and CSF.通过单分子阵列免疫检测法(Simoa)测量血浆和脑脊液中磷酸化tau蛋白181(p-tau181)对阿尔茨海默病轻度认知障碍进行鉴别诊断
Front Mol Neurosci. 2024 Jan 8;16:1288930. doi: 10.3389/fnmol.2023.1288930. eCollection 2023.
6
Comparison of performance in neuropsychological tests in amnestic Mild Cognitive Impairment and Alzheimer's disease patients.遗忘型轻度认知障碍和阿尔茨海默病患者神经心理学测试表现的比较。
Dement Neuropsychol. 2009 Jan-Mar;3(1):41-48. doi: 10.1590/S1980-57642009DN30100009.
7
Conscious attention defect and inhibitory control deficit in Parkinson's Disease-Mild Cognitive Impairment: A comparison study with Amnestic Mild Cognitive Impairment multiple domain.帕金森病-轻度认知障碍中的意识注意缺陷和抑制控制缺陷:与遗忘型轻度认知障碍多领域的比较研究
Psychiatr Danub. 2017 Dec;29(4):437-445. doi: 10.24869/psyd.2017.437.
8
Predictors of independence in instrumental activities of daily living: Amnestic versus nonamnestic MCI.日常生活工具性活动独立性的预测因素:遗忘型与非遗忘型轻度认知障碍
J Clin Exp Neuropsychol. 2016 Nov;38(9):991-1004. doi: 10.1080/13803395.2016.1181716. Epub 2016 May 31.
9
Diagnostic Performance of a Tablet Computer-Based Cognitive Screening Test for Identification of Amnestic Mild Cognitive Impairment.基于平板电脑的认知筛查测试对遗忘型轻度认知障碍识别的诊断性能。
J Korean Med Sci. 2023 May 1;38(17):e131. doi: 10.3346/jkms.2023.38.e131.
10
Brain metabolism and cerebrospinal fluid biomarkers profile of non-amnestic mild cognitive impairment in comparison to amnestic mild cognitive impairment and normal older subjects.与遗忘型轻度认知障碍及正常老年受试者相比,非遗忘型轻度认知障碍的脑代谢和脑脊液生物标志物特征
Alzheimers Res Ther. 2015 Sep 15;7(1):58. doi: 10.1186/s13195-015-0143-0.

引用本文的文献

1
Alzheimer's disease digital biomarkers multidimensional landscape and AI model scoping review.阿尔茨海默病数字生物标志物的多维全景与人工智能模型范围综述
NPJ Digit Med. 2025 Jun 16;8(1):366. doi: 10.1038/s41746-025-01640-z.

本文引用的文献

1
Dementia prevention, intervention, and care: 2024 report of the Lancet standing Commission.《痴呆症的预防、干预与照护:柳叶刀常设委员会2024年报告》
Lancet. 2024 Aug 10;404(10452):572-628. doi: 10.1016/S0140-6736(24)01296-0. Epub 2024 Jul 31.
2
FACEmemory®, an Innovative Online Platform for Episodic Memory Pre-Screening: Findings from the First 3,000 Participants.FACEmemory®,一个用于情景记忆预筛查的创新型在线平台:来自前 3000 名参与者的发现。
J Alzheimers Dis. 2024;97(3):1173-1187. doi: 10.3233/JAD-230983.
3
Lecanemab: Appropriate Use Recommendations.
仑卡奈单抗:合理使用建议。
J Prev Alzheimers Dis. 2023;10(3):362-377. doi: 10.14283/jpad.2023.30.
4
2023 Alzheimer's disease facts and figures.2023 年阿尔茨海默病事实和数据。
Alzheimers Dement. 2023 Apr;19(4):1598-1695. doi: 10.1002/alz.13016. Epub 2023 Mar 14.
5
Digital Cognitive Biomarker for Mild Cognitive Impairments and Dementia: A Systematic Review.轻度认知障碍和痴呆的数字认知生物标志物:一项系统综述。
J Clin Med. 2022 Jul 19;11(14):4191. doi: 10.3390/jcm11144191.
6
Automatized FACEmemory® scoring is related to Alzheimer's disease phenotype and biomarkers in early-onset mild cognitive impairment: the BIOFACE cohort.自动化FACEmemory®评分与早发性轻度认知障碍中的阿尔茨海默病表型和生物标志物相关:BIOFACE队列研究
Alzheimers Res Ther. 2022 Mar 18;14(1):43. doi: 10.1186/s13195-022-00988-8.
7
The Epidemiology of Alzheimer's Disease Modifiable Risk Factors and Prevention.阿尔茨海默病的流行病学:可改变的危险因素和预防。
J Prev Alzheimers Dis. 2021;8(3):313-321. doi: 10.14283/jpad.2021.15.
8
A computerized version of the Short Form of the Face-Name Associative Memory Exam (FACEmemory®) for the early detection of Alzheimer's disease.一种用于早期检测阿尔茨海默病的人脸联想记忆测验(FACEmemory®)简体中文简化版的计算机版本。
Alzheimers Res Ther. 2020 Mar 16;12(1):25. doi: 10.1186/s13195-020-00594-6.
9
Impact of Recruitment Methods in Subjective Cognitive Decline.招募方法对主观认知衰退的影响。
J Alzheimers Dis. 2017;57(2):625-632. doi: 10.3233/JAD-160915.
10
Concordance between Subjective and Objective Memory Impairment in Volunteer Subjects.志愿者受试者主观与客观记忆损害之间的一致性。
J Alzheimers Dis. 2015;48(4):1109-17. doi: 10.3233/JAD-150594.